$GANX Posted About The Data ⬇️
Do We Finally See This Stock Breakout And Reach its TRUE Market Value???
Remember This Play Was ALWAYS a Long Term Hold, Not Really a Trade Folks
Could Be Fireworks Incoming… 👀
$GANX Posted About The Data ⬇️
Do We Finally See This Stock Breakout And Reach its TRUE Market Value???
Remember This Play Was ALWAYS a Long Term Hold, Not Really a Trade Folks
Could Be Fireworks Incoming… 👀
$GANX A Name I Have Consistently Posted For Over a Year Now, Expecting Very Positive Results Next Month, Make Sure You Keep This On HEAVY Watch Sub $2.00. @GainThera
$GANX Gain Therapeutics very unique approach for stopping Parkinsons
One week until Phase 1b Interim data in Parkinson's patients.
AI Drug Discovery Targets Parkinson’s at Its Root | Technology Networks
technologynetworks.com/drug-discovery…
$GANX Gain Therapeutics Two weeks until Phase 1b Interim data on Parkinson’s drug GT-02287
Gain Therapeutics(GANX): September Updated Analyst Reports with Average Target of $8
gaintherapeutics.wordpress.com/2025/09/12/gai…
$GANX Gain Therapeutics will present interim data of its Phase 1b Parkinson’s drug trial as a poster on October 7th as part of the International Parkinson’s and Movement Disorder Congress.
Gain Therapeutics @GainThera announces that it has received Australian approval of a 9-month extension for its Phase 1b dosing study of of GT-022887 (GCase modulator for #Parkinsons) & reports positive independent data monitoring committee recommendation
gaintherapeutics.com/newsroom/press…
$COYA FDA clears IND for lead investigational ALS candidate COYA 302, unlocking $8.4M milestone funding from Dr. Reddy’s. Watch more from CEO Arun Swaminathan on what this means for investors:
Coya Therapeutics has announced that the FDA has accepted its Investigational New Drug (IND) application for COYA 302’s Phase 2 Trial in #ALS. This milestone marks a critical step forward as we advance our mission of delivering hope and new options to those living with ALS. $COYA…
Join me and @SullyCNBC today at 2 pm ET on @CNBC@PowerLunch, where we'll discuss $WULF's transformative 200+ MW, 10-Year AI hosting agreement with world-class capital and compute partners @fluidstackio and @Google 🐺
Tune into a conversation between Gene Mack, Gain President and CEO, and Donald Tracy from Pharmaceutical Executive. $GANX #Parkinsonspharmexec.com/view/early-tri…
$GANX Gain Therapeutics latest note from Scotiabank target $12
Gain Therapeutics(GANX): Scotiabank 7/8/25 Note with Target of $12: Positive Vibes Post NDR with GANX
gaintherapeutics.wordpress.com/2025/07/09/gai…
51K Followers 2K Following🐝 Making traders profitable one bee at a time | Founder of Vivi’s Trading Hive | My tweets are my opinions, not financial advice 📊
36 Followers 240 FollowingThe Idea that humans are tribal and the Idea that we evolved somehow isn't the idea that sets us free, it's the idea that enslaves us Vene Vidi Vici.
5K Followers 3K FollowingThe PRISM stock indexes track small/micro-cap companies across a diverse spectrum of industries including clean energy, biotech and next-gen tech.
31 Followers 70 FollowingContrarian at heart. Buying the fear when everyone else is selling. ❤️ The best deals are found in the wreckage. $PTON | $PYPL | $SQ | $ZM.
125 Followers 737 FollowingBig Picture thinker interested in getting to the root cause of every problem. Full Stack Software engineer working on Drupal/React, Java/Spring, AWS, Pantheon.
1K Followers 2K FollowingTim has put together several algorithms that query the financial data on all of the US exchanges for making stock and options trades. Not financial advice.
51K Followers 2K Following🐝 Making traders profitable one bee at a time | Founder of Vivi’s Trading Hive | My tweets are my opinions, not financial advice 📊
114K Followers 250 FollowingHelping You Win Fantasy Football Leagues || Creator of @NoExpertFF || Join Discord for Answers to All Questions, Rankings, and Bonus Content
483K Followers 747 FollowingConsensus fantasy football advice, tools and accuracy tracking from 200+ experts to help you dominate 💪 IG: @FantasyPros https://t.co/ZPsDOoBNLz
5K Followers 495 FollowingRenergen is a producer of liquefied natural gas (LNG) & helium, which holds the rights to rich renewable natural gas fields.Dual listed on JSE ($REN) ASX (RLT)
391 Followers 19 Following📊Buffett follower, focusing on stock analysis | cryptocurrency | trading signals | All tweets represent personal opinions only and do not constitute investme❌
1K Followers 2K FollowingTim has put together several algorithms that query the financial data on all of the US exchanges for making stock and options trades. Not financial advice.
35K Followers 612 FollowingOfficial Twitter account for Pharmaceutical Executive, a digital and print magazine offering news and opinions, analysis, features and executive profiles.
3K Followers 1K FollowingManaging Partner at @CH1EFpartners Prev. Head of Market Intel at Bakkt, Ex SVP at Citi, Ex Visa. Digital Assets & Fintech Executive. Georgetown University MBA
93 Followers 121 FollowingUshering in a new era of hope for the millions of people living with neurodegenerative diseases by discovering and developing next-generation medicines.
6K Followers 2K FollowingStreetwise Reports is the leading source of news & investing ideas in gold, precious metals, mining, energy, renewables, biotech, life sciences & technology.
680 Followers 460 FollowingStocks. Options. Precision. I trade the charts, spot the setups, and call the moves. I blend strategy with execution. $₿ Free 👉 https://t.co/3Evi8JrKAD
16K Followers 322 FollowingWe are energy experts, developing and operating sustainably powered data centers for efficient, advanced digital applications.
48K Followers 413 FollowingNews about #STMicroelectronics – a global #semiconductor leader serving customers across the spectrum of #electronics applications
1K Followers 284 FollowingWelcome to the official account of #Soitec, a world leader in innovative #semiconductor materials.
🚀 Stay tuned to catch our latest news !